The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert warning Nigerians about the circulation of counterfeit cancer medications, including Avastin and Tecentriq, across the country.
In a statement, the agency confirmed reports of falsified batches of Avastin 400mg/16ml and Tecentriq 1200mg/20ml, following complaints from healthcare professionals nationwide.
The alert was triggered after Roche Nigeria identified discrepancies between suspected counterfeit products and authentic samples. Investigations revealed that the fake drugs were being sold at significantly lower prices, ranging from ₦180,000 to ₦350,000, raising concerns among patients and medical practitioners.
NAFDAC reported multiple inconsistencies in the counterfeit products, including invalid batch numbers, substandard packaging, incorrect text placement, and irregular serialisation. Among the specific counterfeit batches flagged are Avastin H4239A70, H2290A34, and A3508B02, as well as Tecentriq B3071A12.
The agency warned that counterfeit oncology drugs may contain little or no active ingredients, harmful substances, or incorrect dosages. Such products pose serious health risks, including treatment failure, disease progression, severe complications, or even death.
To combat the circulation of these fake medicines, NAFDAC has instructed its zonal directors and state coordinators to intensify surveillance and remove counterfeit products from the market.
The public, including importers, distributors, healthcare providers, and patients, has been urged to exercise vigilance and ensure medicines are sourced only from authorised and verified suppliers. Members of the public are also encouraged to report suspected counterfeit or substandard medicines via NAFDAC’s official channels.









